相关实验视频
Updated: Sep 12, 2025

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
363
对个性化类风湿关节炎药物推进行图形嵌入增强层次模型
Shuyu Ouyang1, Yu Tian1, Dubai Li1
1College of Biomedical Engineering and Instrument Science, Zhejiang University, Engineering Research Center of EMR and Intelligent Expert System, Ministry of Education, Hangzhou 310027, China.
Studies in health technology and informatics
|August 8, 2025
概括
一个新的AI系统通过分析患者数据和药物相互作用来改善类风湿性关节炎 (RA) 药物建议. 这种个性化的方法提高了这种慢性自身免疫性疾病的治疗效率.
科学领域:
- 人工智能的人工智能
- 药理学 药理学是指药理学的学科.
- 类风湿病学 类风湿病学
背景情况:
- 类风湿性关节炎 (RA) 是一种慢性自身免疫性疾病,治疗选择有限,缓解率低.
- 有效的药物选择对于管理RA和改善患者的治疗结果至关重要.
- 目前的治疗策略往往缺乏个性化,导致不理想的反应.
研究的目的:
- 开发和评估一种针对类风湿性关节炎 (RA) 的等级性药物推系统.
- 通过将患者特征与来自电子健康记录 (EHR) 和药物相互作用 (DDI) 数据的图形嵌入整合来增强药物选择.
- 根据预测的药物类别和子类别,为RA患者个性化药物推.
主要方法:
- 使用双层图形卷积网络 (GCN) 来处理EHR和DDI矩阵.
- 患者特征表示与图形嵌入集成,用于药物类预测.
- 使用分层方法,通过药物子类信息来完善预测.
- 研究人员利用了来自352家中国医院的4975名RA患者 (2000-2023) 的数据.
主要成果:
- 与现有方法相比,开发的模型表现出优越的性能.
- 在F1得分 (9%) 和AUC得分 (19%) 中观察到显著改善.
- 该系统有效地预测了RA治疗的药物类别和子类别.
结论:
- 增强的药物推系统显示了个性化RA药物的巨大潜力.
- 这种人工智能驱动的方法可以优化药物选择并提高RA管理中的治疗疗效.
- 进一步的研究可以探索这种模型在慢性疾病管理中的更广泛应用.
相关概念视频
Genome-wide Association Studies-GWAS
14.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.2K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Rheumatic Heart Disease III: Medical Management
32
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
32
Cardiovascular Drugs: Classification based on Therapeutic Indications
3.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.2K
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K
Pharmacokinetic Models: Overview
1.1K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.1K

